Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

3.72B

Market cap3.72B

Price-Earnings ratio

-14.67

Price-Earnings ratio-14.67

Dividend yield

—

Dividend yield—

Average volume

3.14M

Average volume3.14M

High today

$39.64

High today$39.64

Low today

$37.76

Low today$37.76

Open price

$39.35

Open price$39.35

Volume

2.37M

Volume2.37M

52 Week high

$173.25

52 Week high$173.25

52 Week low

$34.10

52 Week low$34.10

SRPT News

Simply Wall St 4d

Sarepta Therapeutics (NasdaqGS:SRPT) Gains 19% Over Past Month Following Japan Approval

saw its share price rise by 19% over the past month, a move that notably outpaced the broader market's 1% increase for the week and the 13% gain over the year....

Seeking Alpha 6d

Sarepta upgraded at Scotiabank on attractive risk reward setup

Shares of Sarepta Therapeutics (NASDAQ:SRPT) traded higher in the premarket on Friday after Scotiabank upgraded the biotech to Sector Outperform from Sector Per...

Analyst ratings

85%

of 27 ratings

Buy

85.2%

Hold

14.8%

Sell

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.